 |
 |
 |
|
Refill pouch mycolio disinfectant wipes, 61191, 6"x7" wipes, 160 wipes/pouch, 6 pouch/case
*EPA APPROVED for use against covid-19 on List N View FAQ's for how to navigate List N
mycolio DISINFECTANT WIPES are effective against HIV-1, Hepatitis B (DHBV) and Hepatitis C (BVDV). Low lint, heavy duty, non-woven, pre-saturated wipes. May be used on a multitude of non porous hard surfaces to inactivate a broad spectrum of pathogenic microorganisms - Bactericide, Virucide, Tuberculocide and Fungicide and and at the same time also gentle enough to use on dental chairs.
mycolio DISINFECTANT WIPES have a unique formulation of four active
ingredients that work synergistically to create an unparalleled broad spectrum
disinfectant ideal for daily use in dental offices. mycolio DISINFECTANT WIPES
can be used on a multitude of hard surfaces to inactivate a broad spectrum of
pathogenic microorganisms. View Ingredients
Features & Benefits:
- Broad Spectrum Bactericide, Virucide, Tuberculocide and Fungicide
- Meets CDC guidelines for intermediate level surface disinfection
- Cleaner and disinfectant in one product; save money, time and storage space
- Compatible with a wide range of hard, non-porous surfaces
- Low lint, 6” x 7” heavy duty, non-woven, pre-saturated wipes
- Packaged in recyclable HDPE tubs with self-closing dispenser lids
- Convenient refill rolls are available to reduce waste and save you money
|
Product Code
|
Description
|
Wipe Dimensions
|
Mfr. Code
|
Quantity
|
Price Per Case
1-9 | Price Per Case
10-24 | Price Per Case
25+
|
| C-MDW160 |
mycolio™ Disinfectant Wipes
|
6" x 7"
|
61161
|
160 wipes/tub
6 tubs/case
|
$108.00/case | $102.60/case | $197.20/case |
| C-MDW-P |
Refill Pouch, mycolio™ Disinfectant Wipes
|
6" x 7" |
61191 |
160 wipes/pouch
6 pouches/case |
$126.00/case | $119.70/case | $113.40/case |
Quantity Discounts will be applied in shopping cart.
EPA Registration Number: 88897-2-90841
1-minute contact timeHuman Immunodeficiency virus type 1 (HIV-1)*
2-minute contact time Vancomycin Resistant Enterococcus faecalis (VRE) Methicillin Resistant Staphylococcus aureus (MRSA) Duck Hepatitis B Virus (Surrogate for Human Hepatitis B Virus)* Bovine Viral Diarrhea Virus (Surrogate for Human Hepatitis C Virus)* Avian Influenza A (H3N2) Reassortant virus Salmonella enterica
3-minute contact time Mycobacterium bovis BCG Pseudomonas aeruginosa Staphylococcus aureus Poliovirus Type 1 Trichophyton mentagrophytes
*mycolio DISINFECTANT has demonstrated effectiveness against viruses similar to Novel Coronavirus 2019-nCoV on hard, non-porous surfaces. Therefore, mycolio DISINFECTANT can be used against Novel Coronavirus 2019-nCoV when used in accordance with the directions for use against Adenovirus type 5 [ATCC VR-5] on hard, non-porous surfaces. Refer to the CDC website at https://www.cdc.gov/coronavirus/2019-nCoV/summary... for additional information.
Active Ingredients:
- n-Alkyl (50% C14, 40% C12, 10% C16)
-
dimethyl benzyl ammonium chloride 0.34%
-
Didecyl dimethyl ammonium chloride 0.51%
-
Ethanol 6.84%
-
Isopropanol 13.68%
Special Instructions for Cleaning and Decontamination Against HIV-1, HBV, and HCV of Surfaces or Objects Soiled With Blood or Body Fluids: Personal Protection: When using this disinfecting towelette, wear appropriate barrier protection such as disposable protective gloves, protective gown, face mask and eye covering. Cleaning Procedure: Blood and other body fluids must be thoroughly cleaned from surfaces and objects before application of this disinfecting towelette. A mycolio Disinfectant Wipe can be used for this purpose. Contact Time: Allow surface to remain wet for 1 minute to kill HIV-1. Use a 2 minute contact time for HBV and HCV. Disposal of Infectious Materials: Cleaning materials used that may contain blood or other body fluids should be autoclaved and disposed of in accordance with Federal, State and local regulations for infectious materials disposal.
mycolio disinfectant wipe safety data sheetmycolio disinfectant wipes brochure
*This product effectively kills Human Immunodeficiency virus 1 (HIV-1), Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV) on pre-cleaned environmental surfaces/objects previously soiled with blood/body fluids in healthcare settings or other settings in which there is an expected likelihood of soiling of inanimate surfaces/objects with blood/body fluids, and in which the surfaces/objects can be associated with the potential for transmission of HIV-1, HBV, and HCV.
|
|
|
 |
|
 |
|
